Shareholders May Find It Hard To Justify Increasing CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) CEO Compensation For Now

Key Insights CytomX Therapeutics will host its Annual General Meeting on 15th of May Total pay for CEO Sean McCarthy includes US$652.1k salary The total compensation is similar to the average for

Simply Wall StMay 10 08:30 ET

Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

Wednesday, CytomX Therapeutics Inc (NASDAQ:CTMX) released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-canc

BenzingaMay 9 14:59 ET

Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Thursday.The Dow traded up 0.48% to 39,244.53 while the NASDAQ rose 0.32% to 16,354.20. The S&P 50

BenzingaMay 9 12:01 ET

Earnings Call Summary | CytomX(CTMX.US) Q1 2024 Earnings Conference

The following is a summary of the CytomX Therapeutics, Inc. (CTMX) Q1 2024 Earnings Call Transcript:Financial Performance:As of Q1 2024, CytomX reported a cash position of $150 million, expected to pr

moomoo AIMay 9 11:42 ET · Conference Call

CytomX Therapeutics Is Maintained at Market Perform by BMO Capital

CytomX Therapeutics Is Maintained at Market Perform by BMO Capital

Dow JonesMay 9 11:05 ET

Express News | HC Wainwright & Co. Reiterates Neutral on CytomX Therapeutics

BenzingaMay 9 10:08 ET